Benjamin R Yerxa Net Worth

The estimated Net Worth of Benjamin R Yerxa is at least $23.5 Tisíc dollars as of 15 May 2024. Benjamin Yerxa owns over 7,813 units of Clearside Biomedical Inc stock worth over $23,524 and over the last 3 years Benjamin sold CLSD stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Benjamin Yerxa CLSD stock SEC Form 4 insiders trading

Benjamin has made over 1 trades of the Clearside Biomedical Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Benjamin bought 7,813 units of CLSD stock worth $10,235 on 15 May 2024.

The largest trade Benjamin's ever made was buying 7,813 units of Clearside Biomedical Inc stock on 15 May 2024 worth over $10,235. On average, Benjamin trades about 1,563 units every 0 days since 2022. As of 15 May 2024 Benjamin still owns at least 17,957 units of Clearside Biomedical Inc stock.

You can see the complete history of Benjamin Yerxa stock trades at the bottom of the page.

What's Benjamin Yerxa's mailing address?

Benjamin's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.

Insiders trading at Clearside Biomedical Inc

Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp a Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.

What does Clearside Biomedical Inc do?

clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.

Complete history of Benjamin Yerxa stock trades at Clearside Biomedical Inc

Clearside Biomedical Inc executives and stock owners

Clearside Biomedical Inc executives and other stock owners filed with the SEC include:

• George Lasezkay,
  President, Chief Executive Officer, Director
• Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
  Pres, CEO & Director
• Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
  Pres, CEO & Director
• Charles Deignan,
  Chief Financial Officer
• Dr. Thomas A. Ciulla M.B.A., M.D.,
  Chief Medical Officer & Chief Devel. Officer
• Charles A. Deignan,
  Chief Financial Officer
• Jenny Kobin,
  IR Contact Officer
• Clay Thorp,
  Independent Director
• Nancy Hutson,
  Independent Director
• William Humphries,
  Independent Director
• Jeffrey Edwards,
  Independent Director
• Richard Croarkin,
  Independent Director
• Christy Shaffer,
  Independent Chairman of the Board
• Susan L. Coultas Ph.D.,
  Chief Clinical Officer
• Rick McElheny,
  VP of Corp. Devel.
• Leslie B. Zacks,
  Gen. Counsel, Chief Compliance Officer & Sec.
• Jenny R. Kobin,
  Head of Investor Relations
• Venture Advisors Iii, Llc H...,
  
• Venture Advisors Iv Sbic, L...,
  
• Venture Advisors Iii, Llc H...,
  
• Evgeny Zaytsev,
  Director
• Daniel H. White,
  President and CEO
• Investments S.A.R.L.Rusnano...,
  
• Derek Yoon,
  Director
• Gerald D. Cagle,
  Director
• Venture Advisors Iv Sbic, L...,
  
• Glenn Noronha,
  Executive Vice President, R&D
• Thomas Ciulla,
  Chief Medical Officer
• Brion S. Raymond,
  Chief Commercial Officer
• Anthony S Gibney,
  
• Bradford T Whitmore,
  10% owner
• Ngai Hang Victor Chong,
  Chief Medical Officer
• Benjamin R Yerxa,